» Articles » PMID: 31699335

Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2019 Nov 9
PMID 31699335
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) generates valuable resources for disease modeling, toxicology, cell therapy, and regenerative medicine. However, the reprogramming process can be stochastic and inefficient, creating many partially reprogrammed intermediates and non-reprogrammed cells in addition to fully reprogrammed iPSCs. Much of the work to identify, evaluate, and enrich for iPSCs during reprogramming relies on methods that fix, destroy, or singularize cell cultures, thereby disrupting each cell's microenvironment. Here, we develop a micropatterned substrate that allows for dynamic live-cell microscopy of hundreds of cell subpopulations undergoing reprogramming while preserving many of the biophysical and biochemical cues within the cells' microenvironment. On this substrate, we were able to both watch and physically confine cells into discrete islands during the reprogramming of human somatic cells from skin biopsies and blood draws obtained from healthy donors. Using high-content analysis, we identified a combination of eight nuclear characteristics that can be used to generate a computational model to predict the progression of reprogramming and distinguish partially reprogrammed cells from those that are fully reprogrammed. This approach to track reprogramming in situ using micropatterned substrates could aid in biomanufacturing of therapeutically relevant iPSCs and be used to elucidate multiscale cellular changes (cell-cell interactions as well as subcellular changes) that accompany human cell fate transitions.

Citing Articles

Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.

Molugu K, Khajanchi N, Lazzarotto C, Tsai S, Saha K CRISPR J. 2023; 6(5):473-485.

PMID: 37676985 PMC: 10611976. DOI: 10.1089/crispr.2023.0033.


Defined Microenvironments Trigger In Vitro Gastrulation in Human Pluripotent Stem Cells.

Srivastava P, Romanazzo S, Kopecky C, Nemec S, Ireland J, Molley T Adv Sci (Weinh). 2022; 10(5):e2203614.

PMID: 36519269 PMC: 9929265. DOI: 10.1002/advs.202203614.


Label-Free Imaging to Track Reprogramming of Human Somatic Cells.

Molugu K, Battistini G, Heaster T, Rouw J, Guzman E, Skala M GEN Biotechnol. 2022; 1(2):176-191.

PMID: 35586336 PMC: 9092522. DOI: 10.1089/genbio.2022.0001.


Multiscale Genome Organization: Dazzling Subject and Inventive Methods.

Schlick T Biophys J. 2020; 118(9):E1-E3.

PMID: 32305070 PMC: 7161524. DOI: 10.1016/j.bpj.2020.04.007.

References
1.
Inoue H, Nagata N, Kurokawa H, Yamanaka S . iPS cells: a game changer for future medicine. EMBO J. 2014; 33(5):409-17. PMC: 3989624. DOI: 10.1002/embj.201387098. View

2.
Walsh A, Cook R, Manning H, Hicks D, Lafontant A, Arteaga C . Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res. 2013; 73(20):6164-74. PMC: 3801432. DOI: 10.1158/0008-5472.CAN-13-0527. View

3.
Loh Y, Wu Q, Chew J, Vega V, Zhang W, Chen X . The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006; 38(4):431-40. DOI: 10.1038/ng1760. View

4.
Meshorer E, Yellajoshula D, George E, Scambler P, Brown D, Misteli T . Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell. 2006; 10(1):105-16. PMC: 1868458. DOI: 10.1016/j.devcel.2005.10.017. View

5.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View